drugset / Trial / NCT00873223
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
Non-randomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted in the United States. The aim of this clinical trial is to investigate whether chronic liraglutide administration affects the mode of action (pharmacokinetics) of insulin detemir
Timeline
- Start
- 2009-03
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |
| Subject | insulin detemir | Protein / enzyme biologic | 0.5 iu/kg | — |